Skip to content

The Effect of Preoperative Oral Carbohydrate Intake on Postoperative Recovery Quality in Patients Undergoing Laparoscopic Colorectal Surgery

The Effect of Preoperative Oral Carbohydrate Intake on Postoperative Recovery Quality in Patients Undergoing Laparoscopic Colorectal Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114854
Enrollment
Unknown
Registered
2025-12-18
Start date
2024-09-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Group C:The patient should take 400 ml of OECNS 2 to 4 hours before surgery
Group W:The patient should drink 400 ml of purified water 2 to 4 hours before surgery.

Sponsors

The Second Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Age between 65 and 90; (2) Patients undergoing laparoscopic radical resection for colorectal cancer; (3) American Society of Anesthesiologists (ASA) physical status classification of II-III.

Exclusion criteria

Exclusion criteria: (1) Patients with a history of mental illness who are unable to communicate normally; (2) Patients with renal insufficiency or liver function classified as Child-Pugh Grade B or higher; (3) Patients with malnutrition, a history of diabetes, or other endocrine disorders; (4) Cases converted to open surgery during the procedure; (5) Patients currently using medications affecting glucose metabolism, such as corticosteroids; (6) Patients receiving allogeneic blood transfusion, glucose infusion, or exogenous insulin infusion during surgery; (7) Patients with gastroesophageal reflux disease, achalasia, gastric stasis, hiatal hernia, pancreatic disease, etc.; (8) Patients transferred to the ICU or AICU postoperatively; (9) Patients with muscle weakness associated with autoimmune diseases, such as myasthenia gravis, amyotrophic lateral sclerosis, and multiple sclerosis.

Design outcomes

Primary

MeasureTime frame
The recovery quality of 15 items was evaluated on the 1st, 2nd, and 3rd days after the operation.;Postoperative fatigue scores were evaluated on the 1st, 2nd, and 3rd days after surgery.;

Secondary

MeasureTime frame
Visual analogue scale was used to evaluate the scores of thirst and dizziness on the 1st, 2nd and 3rd days after surgery.;Blood glucose and C-reactive protein;Intraoperative hemodynamic parameters,Including intraoperative mean arterial pressure and heart rate;

Countries

China

Contacts

Public ContactDongnan Hou

The Second Affiliated Hospital of Dalian Medical University

1936947743@qq.com+86 177 0987 2323

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026